Beta Bionics, Inc. (BBNX) has 15 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 14 sales totalling $3.1M. Most recent filing: Sept. 18, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 18, 2026 filed Sept. 9, 2026 | Hopman Mark Chief Commercial Officer | −$664,550 | 35,994 | −29% | Yes | |
|
|
||||||
| Sept. 17, 2026 filed Sept. 16, 2026 | Hopman Mark Chief Commercial Officer | −$619,640 | 30,779 | −35% | Yes | |
|
|
||||||
| Sept. 17, 2026 filed Sept. 16, 2026 | Mensinger Mike Chief Product Officer | −$58,300 | 2,650 | −1% | Yes | |
|
|
||||||
| Sept. 15, 2026 filed Sept. 14, 2026 | Hopman Mark Chief Commercial Officer | −$12,028 | 775 | −1% | Yes | |
|
|
||||||
| Sept. 10, 2026 filed Sept. 9, 2026 | Hopman Mark Chief Commercial Officer | −$680,723 | 36,870 | −30% | Yes | |
|
|
||||||
Showing the 5 most recent of 15 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free